Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03396497
Title Study of LYC-55716 With Pembrolizumab in Adult Subjects With Non-Small Cell Lung Cancer
Recruitment Unknown status
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Lycera Corp.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Lycera Investigational Site Aurora Colorado 80045 United States Details
Lycera Investigational Site Ann Arbor Michigan 48109 United States Details
Lycera Investigational Site Nashville Tennessee 37203 United States Details
Lycera Investigational Site Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field